index
At Novartis, we are reimagining medicine
Novartis Financial Results – Q1 2021
Novartis announced the company’s financial results for the first quarter of 2021.
Building clinical trial diversity for long-term equity
Vas Narasimhan reflects on how to increase diversity in clinical trials.
COVID-19 US Information Center
Novartis is responding to the coronavirus disease (COVID-19) outbreak. The information center provides a central hub for news, guidance and resources.
Novartis in Society 2020 US Report
Novartis is striving every day to help patients, strengthen communities, drive sustainability, and build a more equitable and responsive healthcare system for all.
Notice to Healthcare Providers and Entities
Novartis enters into Corporate Integrity Agreement with Office of Inspector General (OIG) of the US Department of Health & Human Services.
Novartis US at a Glance
Learn more about Novartis in the US and our impact on patients, families and their communities.
AveXis renamed Novartis Gene Therapies, signifying the growing importance of gene therapy to Novartis corporate strategy
Standing for Racial Equity and Justice as One Novartis
We believe unequivocally that Black Lives Matter. As a company focused on improving human health globally, we also recognize the disparities Black communities and communities of color face when it comes to healthcare.